Month: September 2020

Reference is made to the stock exchange notice by Aqua Bio Technology ASA (the “Company“) on 25 August 2020 regarding, inter alia, a subsequent offering with gross proceeds of up to NOK 2,526,000 through issuance of up to 505,200 new shares at a subscription price of NOK 5 per share (the “Subsequent Offering“).The application period in the Subsequent Offering ended on 10 September at 16.30 CEST. At the end of the application period, the Company had received applications corresponding to the maximum amount of shares that can be allocated in the Subsequent Offering. The new shares will be subscribed both through subscription rights and from investors who participated in the private placements announced on 17 and 18 August 2020.The Company`s board of directors (the “Board“) has now allocated shares in...

Det vises til børsmelding sendt av Aqua Bio Technology ASA (“Selskapet“) den 25. august 2020 vedrørende, blant annet, en etterfølgende reparasjonsemisjon med bruttoproveny på opptil NOK 2 526 000 gjennom utstedelse av inntil 505 200 nye aksjer til en tegningskurs på NOK 5 per aksje (den “Etterfølgende Emisjonen“).Bestillingsperioden i den Etterfølgende Emisjonen endte 10. september 2020 kl. 16.30. Ved utløpet av bestillingsperioden hadde Selskapet mottatt bestillinger for nye aksjer tilsvarende det totale antallet aksjer som kan tildeles i den Etterfølgende Emisjonen. De nye aksjene tegnes både gjennom tegningsretter og fra investorer som deltok i de rettede emisjonene offentliggjort 17. og 18. august 2020.Selskapets styre har nå allokert de tegnede aksjene i Reparasjonsemisjonen og Selskapet vil således utstede...

Aqua Bio Technology ASA has publised minutes from Extraordinary General Meeting held 11 September 2020.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.AttachmentABT ASA Signed EGM minutes 11 September 2020

Aqua Bio Technology ASA har offentliggjort protokoll fra ekstraordinær generalforsamling avholdt 11. september 2020.Denne opplysningen er informasjonspliktig etter verdipapirhandelloven § 5-12.VedleggABT ASA Signed EGM minutes 11 September 2020

MELBOURNE, Australia, Sept. 11, 2020 (GLOBE NEWSWIRE) — Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is delighted to announce that initial sales of its GeneType for Breast Cancer Risk Assessment have now commenced in the United States via an online health platform, elicity by InTeleLabs, an independent telehealth and personalised medicine company. This portal is secure, Health Insurance Portability and Accountability Act (HIPAA)-compliant.The secure, Health Insurance Portability and Accountability Act (HIPAA)-compliant health platform enables women meeting the required criteria in the United States to purchase the test and receive results via telehealth clinicians. Its national network of clinical oversight for lab testing has made this groundbreaking Breast Cancer Risk Assessment Test...

SHENZHEN, China, Sept. 11, 2020 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP, the “Company”), a leading provider of internet-based smart display screens, and a new-media ecosystem that enables targeted advertising and online retails, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with an investor (the “Investor”) on September 10, 2020.In this financing, the Company is issuing to the investor an aggregate of 222,222 ordinary shares, no par value (the “Ordinary Shares”), a convertible note with principal amount of $1,480,000 and a warrant to purchase 53,333 Ordinary Shares at $9.0 per share. The gross proceeds to the Company from the financing are $2.0 million before deducting estimated offering expenses.For more details of the financing, please see the Company’s Report on Form...

FORT MYERS, Fla., Sept. 11, 2020 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announces the State of Florida purchased, under the Florida Forever program, approximately 10,702 acres of Alico Ranch for $28.5 million pursuant to an option agreement entered into between the State of Florida and Alico.John Kiernan, Alico’s President and Chief Executive Officer, commented, “We are pleased the State of Florida has purchased this acreage on the west side of the Alico Ranch.  This is the second sales transaction we have completed with the State of Florida, aggregating over 16,000 acres.  As discussed in our Alico 2.0 Modernization Plan, we continue to evaluate and sell off ranch assets and generate cashflow to be used in a manner that will be targeted to allow for a greater return for our investors. In...

ALPHARETTA, Ga., Sept. 11, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that its licensing partner, Aura Biosciences, has dosed the first patient in its Phase 2 clinical trial evaluating the safety and efficacy of suprachoroidal administration of AU-011 as a potential first-line treatment for patients with primary choroidal melanoma. Aura is using Clearside’s SCS Microinjector® to deliver AU-011 into the suprachoroidal space (SCS®).Aura also announced that AU-011 passed the Safety Review for the first dose escalation cohort which demonstrated favorable safety data with no safety findings and no adverse events noted. Aura’s preclinical...

NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendant Digital Acquisition Corp. (NYSE: ACND.U) (the “Company”) today announced that, commencing September 14, 2020, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols “ACND” and “ACND WS,” respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol “ACND.U.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order...

TORONTO, Sept. 11, 2020 (GLOBE NEWSWIRE) — CR Capital Corp. (TSX-V / CIT) (“CR Capital” or the “Company“) is pleased to announce that the results from its July 2020 surface rock and soil geochemical sampling program are available for the Glenrock Gold Property (“Property”) located 100 km north of Sault Ste. Marie, Ontario.  The Property consists of 109 cell claims totaling approximately 1,800 hectares and is contiguous to the southeast with the larger Coppercorp Property also held 100% by CR Capital. The exploration program was undertaken in follow-up to the results of the sampling program reported in the January 13, 2020 News Release. During the program, the work focus was on the further assessment of the Glenrock West gold showing area for which 24 rock samples were obtained from outcrop or subcrop and...